Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass

This study has been completed.
Information provided by (Responsible Party):
Meshalkin Research Institute of Pathology of Circulation Identifier:
First received: November 16, 2011
Last updated: October 30, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)